This web publication constitutes a notice for the purposes of regulations 42ZCZS of the Therapeutic Goods Regulations 1990 (the Regulations). In accordance with regulations 42ZCZS, this notice publishes:
- Decisions made by a delegate of the Secretary pursuant to regulations 42ZCZR
- reasons for that final decision
- date of effect of the decision
Glycopyrronium was considered at the ACMS #43 meeting and palmitoylethanolamide at the Joint ACMS-ACCS #37 meeting in November 2023.
Final decision and reasons
We aim to provide documents in an accessible format. If you're having problems using this document, please contact medicines.scheduling@health.gov.au.
Contents
- Notice of final decisions to amend (or not amend) the current Poisons Standard
- Final decisions on proposed amendments referred to the Advisory Committee on Medicines Scheduling (ACMS #43, November 2023)
- Glycopyrronium
- Final decisions on proposed amendments referred to the Advisory Committees on Medicines and Chemicals Scheduling in joint session (ACMS-ACCS #35, November 2023)
- Palmitoylethanolamide (PEA)